Clinical Trial Update: Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update on the safety of RAD301 in healthy volunteers and patients with pancreatic ductal adenocarcinoma or other solid tumors; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Esophageal Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• RAD301

Snippet

Sponsor: Radiopharm Theranostics, Ltd | Conditions: Healthy Volunteers, Pancreatic Ductal Adenocarcinoma | Phase 1 | Status: RECRUITING